Recent Cancer Treatment Research for February 2025
Mantle Cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Advanced Recurrent Ovarian Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| HER2Negative Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Women's Health, Oncology/Hematology
| Metastatic Urothelial Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| FGFRpositive Gastroesophageal Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Diffuse Large B-cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Muscle Invasive Bladder cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Urology, Oncology/Hematology
| Advanced Renal Cell Carcinoma (RCC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Renal
| Low-Grade Upper Tract Urothelial Cancer (LG UTUC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| MALT Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Metastatic HER2 positive breast cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Women's Health, Oncology/Hematology
| Metastatic Castration Resistant Prostate cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
| Metastatic Pancreatic Cancer (MPC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| ER+/ HER2 -ve Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Extensive-Stage Small Cell Lung Cancer (ESCLC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Locally Advanced Pancreatic Cancer (LAPC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Natural Killer T Cell Lymphoma (NKTL) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Advanced Melanoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Triple-refractory Multiple Myeloma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Severe Toxicities in Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Cancer Anorexia - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology
| Ovarian Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Women's Health, Oncology/Hematology, Obstetrics/Gynecology, Reproductive Health
| Cervical Cancer Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Peripheral T-Cell Lymphoma Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Biliary Tract Cancers (BTCs) - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Castrate-Sensitive Prostate Cancer (CSPC)- Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
| Follicular Lymphoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
| Marginal Zone Lymphoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
| Brain Cancer - Epidemiology Forecast–2032
Topics: Cancer Treatment, Drug Discovery, CNS/Neurology, Oncology/Hematology
| Severe Toxicities in Lymphoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Cancer Anorexia - Epidemiology forecast- 2032
Topics: Cancer Treatment, Oncology/Hematology
| Surgery and Radiation Therapy in Brain Cancer- Market Insight, Competive Landscape and Market Forecast- 2026
Topics: Cancer Treatment, Surgical Equipment, CNS/Neurology, Oncology/Hematology
| 2022-2026 Asia-Pacific Cancer Diagnostics Market Opportunities for Major Tumor Markers for Major Tumor Markers: A 18-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation P
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Asia, Oceania
| 2022-2026 Latin America Cancer Diagnostics Market Opportunities for Major Tumor Markers: A 22-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Oppor
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: South America
| 2022-2026 Mexico Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Mexico
| 2022-2026 Russia Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Russia
| 2022-2026 World Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 90 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other T
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Global
| 2022-2026 Latin America Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 22 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: South America
| 2022-2026 Middle East Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 11 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and O
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Middle East
| 2022-2026 UK Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Techno
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: United Kingdom
| 2022-2026 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Techno
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: United States
| 2022-2026 Canada Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Te
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Canada
| 2022-2026 India Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: India
| 2022-2026 Russia Immunodiagnostic Analyzers and Reagents - Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Immunoassays, Oncology/Hematology
Regions: Russia
| Europe and Israel Mobile Applications for Melanoma Detection Market, By Type (Algorithm Analysis Applications, Mole Tracking And Reminder Applications, Educational Applications, Interactive Teaching Applications), By End User (Diagnostic Centers, Patients
Topics: Tablet PC, Skin Care, Cancer Treatment, Hospitals & Clinics, General Facilities, Oncology/Hematology
Regions: Russia, France, Germany, Italy, Spain, United Kingdom, Israel, Europe
| 2021-2025 Russia Cancer Diagnostics Market Outlook - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Russia
| 2021-2025 North America Cancer Diagnostics Market Outlook: US, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
| 2021-2025 Canada Cancer Diagnostics Market Outlook - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada
| 2021-2025 World Cancer Diagnostics Market Outlook: A 97-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for S
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Global
|
Prev | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
